Recombinant Aspergillus clavatus Mediator of RNA polymerase II transcription subunit 10 (nut2)
Description
Overview of Mediator Subunit 10 (nut2)
Mediator subunit 10 (nut2) is a conserved component of the multi-protein Mediator complex, essential for Pol II-dependent transcription. In Aspergillus clavatus, nut2 facilitates promoter-specific recruitment of Pol II and integrates signals from transcription factors to regulate gene expression . Recombinant nut2 refers to the protein produced via heterologous expression systems (e.g., E. coli, yeast) for experimental or industrial use.
Genomic Context
Functional Domains
-
Mediator interaction domain: Facilitates binding to other Mediator subunits (e.g., Srb4, Med6, Rgr1) .
-
Coactivator interface: Critical for bridging transcriptional activators and Pol II machinery .
Key Interactions
Interactions inferred from homologs in Aspergillus fumigatus:
| Interaction Partner | Function | Score |
|---|---|---|
| Srb4 (Med17) | Stabilizes Mediator-Pol II interaction | 0.999 |
| Med6 | Core scaffold for Mediator head module | 0.999 |
| Med7 | Regulates ergosterol biosynthesis and membrane integrity | 0.999 |
| Soh1 (Med31) | Modulates cell wall stress responses | 0.999 |
Data derived from A. fumigatus orthologs .
Production of Recombinant nut2
Recombinant A. clavatus nut2 is commercially synthesized (e.g., MyBiosource MBS1224694) with the following specifications :
| Parameter | Detail |
|---|---|
| Host system | E. coli, yeast, or mammalian cells |
| Purity | >90% (verified via SDS-PAGE) |
| Formulation | Liquid in glycerol buffer |
| Storage | -20°C (long-term); 4°C (working aliquots) |
| Applications | Transcriptional studies, protein interaction assays, drug screening |
Transcriptional Regulation
-
Virulence and stress adaptation: In pathogenic fungi, Mediator subunits like nut2 regulate genes involved in host invasion and antifungal resistance . For example, Candida albicans Med3 (a tail module subunit) coordinates Ace2-dependent genes critical for cell wall integrity .
-
Secondary metabolism: In Aspergillus flavus, Mediator subunits modulate aflatoxin biosynthesis clusters . Recombinant nut2 could enable similar mechanistic studies in A. clavatus.
Industrial Relevance
-
Recombinant protein production: Insights from Aspergillus niger show that optimizing Mediator subunit expression enhances secretory pathways . Overexpression of nut2 might improve yields of industrial enzymes or therapeutics.
Future Directions
Product Specs
Target Background
KEGG: act:ACLA_028660
STRING: 5057.CADACLAP00001884
Q&A
What is the Mediator subunit 10 (nut2) in Aspergillus clavatus and how does it compare to other fungal species?
The Mediator subunit 10 (nut2) in Aspergillus clavatus is a component of the Mediator complex, which serves as a critical coactivator for RNA polymerase II (Pol II)-mediated gene regulation. While specific research on A. clavatus Mediator subunit 10 is limited, comparative analyses suggest it functions similarly to other fungi, particularly in the Aspergillus genus. The Mediator complex participates in multiple steps of the transcription process, including preinitiation complex (PIC) assembly, as documented in studies of Mediator-Pol II interactions . A. clavatus belongs to the Aspergillus section Clavati, and phylogenetic analysis based on β-tubulin gene sequencing shows high conservation within this section, suggesting functional conservation of transcriptional machinery components .
What expression systems are most effective for producing recombinant A. clavatus Mediator subunit 10?
For successful expression of recombinant A. clavatus Mediator subunit 10, researchers should consider:
-
Baculovirus Expression System: The MultiBac baculovirus expression system has proven successful for generating recombinant human core Mediator subcomplexes and would likely be suitable for A. clavatus Mediator components .
-
Bacterial Expression: While no specific data exists for A. clavatus Mediator subunit 10, researchers have successfully expressed and assembled recombinant archaeal RNA polymerase components from purified subunits with full activity .
When selecting an expression system, consider:
-
The need for post-translational modifications
-
Required yield
-
Downstream applications
For functional studies requiring proper folding and interactions, insect cell-based systems are preferable, while bacterial systems may be sufficient for structural or antibody production purposes.
What purification strategy yields the highest purity of recombinant A. clavatus Mediator subunit 10?
While specific purification protocols for A. clavatus Mediator subunit 10 are not directly reported, effective strategies can be adapted from successful approaches used for related proteins:
Recommended Purification Pipeline:
-
Initial capture using affinity chromatography (His-tag or GST-tag)
-
Intermediate purification via ion exchange chromatography
-
Final polishing with size exclusion chromatography
This approach has been successfully employed for other recombinant transcriptional components, including those used in reconstituted transcription systems . For optimal results, perform purification under conditions that maintain native protein structure, typically using buffers containing 20-50 mM Tris-HCl (pH 7.5-8.0), 100-300 mM NaCl, 10% glycerol, and 1-5 mM DTT or β-mercaptoethanol.
How can I verify the structural integrity of purified recombinant A. clavatus Mediator subunit 10?
Verification of structural integrity should employ multiple complementary approaches:
-
Circular Dichroism (CD) Spectroscopy: To assess secondary structure elements
-
Thermal Shift Assay: To determine protein stability and proper folding
-
Limited Proteolysis: To evaluate domain organization and stability
-
Size Exclusion Chromatography with Multi-Angle Light Scattering (SEC-MALS): To confirm monomeric state or proper oligomerization
For functional validation, binding assays with known interaction partners (other Mediator subunits or RNA Pol II components) can provide evidence of correct folding. When analyzing results, compare with published structures of homologous proteins from related species, accounting for the evolutionary conservation observed in the Aspergillus section Clavati .
What experimental approaches can determine if recombinant A. clavatus Mediator subunit 10 is functionally active?
Functional activity of recombinant A. clavatus Mediator subunit 10 can be assessed through:
In vitro Transcription Assays:
-
Reconstitution experiments incorporating the recombinant protein into a minimal transcription system
-
Measurement of basal and activated transcription rates from model promoters
-
Comparison of activity with and without the recombinant subunit
Research on human Mediator complexes demonstrates that reconstituted subcomplexes can facilitate both basal and activated transcription, providing a model for similar experiments with A. clavatus components . For meaningful results, include appropriate controls such as heat-inactivated protein and mutant variants with predicted loss of function.
How does recombinant A. clavatus Mediator subunit 10 interact with RNA Polymerase II?
Based on studies of related systems, interaction analysis between recombinant A. clavatus Mediator subunit 10 and RNA Polymerase II should focus on:
-
Direct Binding Assays: Pull-down experiments, surface plasmon resonance, or isothermal titration calorimetry to quantify binding affinities
-
Crosslinking Mass Spectrometry: To identify specific interaction interfaces
-
Functional Assays: Testing the ability of recombinant RPB1 to compete with or reverse Mediator-Pol II interactions, as demonstrated in human systems
When interpreting results, consider that Mediator complexes directly interact with the C-terminal domain (CTD) of the RPB1 subunit of Pol II, and this interaction is crucial for recruiting Pol II to core promoters . Cryo-EM structural analysis of related yeast Mediator-Pol II complexes may provide templates for modeling A. clavatus interactions.
What controls should be included when studying the effects of A. clavatus Mediator subunit 10 on gene expression?
Essential Controls for Gene Expression Studies:
| Control Type | Purpose | Implementation |
|---|---|---|
| Negative Control | Establish baseline expression | System lacking recombinant Mediator subunit 10 |
| Positive Control | Validate assay functionality | Well-characterized transcription activator |
| Specificity Control | Confirm specific effects | Mutant versions of Mediator subunit 10 |
| Technical Control | Account for experimental variation | Reference genes for normalization |
| Biological Replicates | Address biological variability | Independent experiments (n≥3) |
When designing experiments, be mindful that pre-post with non-equivalent control group studies are particularly vulnerable to threats to internal validity, as differences between treatment and control groups could be erroneously attributed to the intervention . Include controls that account for potential regression to the mean and secular trends that might confound results.
How can I design experiments to study the role of A. clavatus Mediator subunit 10 in secondary metabolite production?
A. clavatus produces various secondary metabolites including cytochalasin E, patulin, and pseurotin A . To investigate the role of Mediator subunit 10 in regulating these pathways:
-
Gene Knockout/Knockdown Approach:
-
Chromatin Immunoprecipitation (ChIP) Analysis:
-
Use tagged recombinant Mediator subunit 10 to perform ChIP experiments
-
Identify genomic binding sites, particularly at secondary metabolite gene clusters
-
Correlate binding with transcriptional activity and metabolite production
-
When analyzing results, consider that secondary metabolite production in A. clavatus is strongly influenced by environmental factors, nutrients, and chromatin structure . Small chemical chromatin effectors like histone deacetylase inhibitors (valproic acid, trichostatin A, butyrate) and DNA-methyltransferase inhibitors (5-azacytidine) have profound influences on secondary metabolite accumulation and biosynthetic gene transcription .
How can recombinant A. clavatus Mediator subunit 10 be used to study transcriptional regulation of plant growth-promoting factors?
A. clavatus produces plant growth-promoting gibberellins (GAs: GA 1, GA 3, and GA 4) and has been isolated as an endophytic fungus from plant roots . To investigate Mediator's role in regulating these pathways:
-
Chromatin Occupancy Analysis:
-
Use recombinant Mediator subunit 10 in ChIP-seq experiments to map binding sites across the A. clavatus genome
-
Correlate binding patterns with genes involved in gibberellin biosynthesis
-
Compare binding profiles under different growth conditions
-
-
Reconstituted Transcription Systems:
-
Establish in vitro transcription assays using recombinant Mediator components including subunit 10
-
Test transcription from promoters of gibberellin biosynthesis genes
-
Analyze the effect of plant-derived signals on transcriptional activity
-
Such studies could reveal how A. clavatus regulates production of plant growth-promoting factors in response to environmental conditions, potentially explaining its beneficial effects on plants observed in studies with Waito-c rice seedlings .
Can structural analysis of A. clavatus Mediator subunit 10 reveal insights into fungal-specific transcriptional regulation?
Structural analysis of A. clavatus Mediator subunit 10 could reveal fungal-specific adaptations in transcriptional regulation. While direct structural data is not currently available, comparative approaches can be informative:
-
Homology Modeling:
-
Generate structural models based on known structures of homologous proteins
-
Compare with structures from other kingdoms to identify fungal-specific features
-
Predict functional surfaces through conservation analysis
-
-
Cryo-EM Analysis:
When analyzing structural data, consider that secondary structure conservation exists between different fungal species (e.g., between human and S. pombe Mediator components) , suggesting functional conservation despite sequence divergence. Fungal-specific structural features might reveal adaptation to the complex regulation of secondary metabolite gene clusters that characterize filamentous fungi like A. clavatus .
What strategies can overcome low expression yields of recombinant A. clavatus Mediator subunit 10?
Low expression yields are a common challenge when working with transcription factors and regulators. If experiencing poor yields of recombinant A. clavatus Mediator subunit 10:
Optimization Strategies:
| Approach | Implementation | Expected Outcome |
|---|---|---|
| Codon Optimization | Adapt codons to expression host preferences | Improved translation efficiency |
| Fusion Tags | Test different solubility tags (MBP, SUMO, TRX) | Enhanced solubility and stability |
| Expression Conditions | Vary temperature (16-30°C), inducer concentration | Reduced inclusion body formation |
| Co-expression | Express with chaperones or binding partners | Improved folding and stability |
| Truncation Constructs | Express stable domains instead of full-length protein | Increased solubility |
When optimizing expression, consider that success has been reported with the MultiBac baculovirus expression system for complex transcriptional components , and that in vitro assembly of recombinant archaeal RNA polymerase from purified subunits yielded fully active enzyme .
How can I troubleshoot non-specific interactions in pull-down assays with recombinant A. clavatus Mediator subunit 10?
Non-specific interactions in pull-down assays can confound interpretation of interaction partners. To improve specificity:
-
Buffer Optimization:
-
Increase salt concentration incrementally (100-500 mM NaCl)
-
Add low concentrations of detergents (0.01-0.1% NP-40 or Triton X-100)
-
Include competitors for non-specific interactions (BSA, tRNA)
-
-
Control Experiments:
-
Include unrelated proteins with similar properties as negative controls
-
Perform reciprocal pull-downs with suspected interaction partners
-
Use mutant versions of Mediator subunit 10 with disrupted interaction surfaces
-
-
Alternative Approaches:
-
Consider crosslinking prior to pull-down for transient interactions
-
Employ proximity labeling techniques (BioID, APEX) for in vivo interaction mapping
-
Validate interactions with orthogonal methods (co-immunoprecipitation, FRET)
-
These methodological refinements can help distinguish true interaction partners from background, leading to more reliable characterization of the A. clavatus Mediator subunit 10 interactome.
